文献速递冠心病

完全血运重建降低STEMI合并多支病变患者心血管死亡:随机临床试验系统综述与荟萃分析

Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials.
PubMed 文献 · Eur Heart J · 2020-01-01

该系统综述与荟萃分析纳入6项随机临床试验,比较STEMI合并多支病变患者完全血运重建与仅罪犯血管血运重建的策略。共6528例患者,随访1至3年(中位2年),完全血运重建组心血管死亡显著降低(HR 0.62,95%CI 0.39-0.97),心肌梗死和重复血运重建也显著减少,全因死亡无显著差异。

要点

  • 完全血运重建显著降低STEMI合并多支病变患者心血管死亡(HR 0.62)。
  • 完全血运重建还显著减少心肌梗死和重复血运重建风险。
  • 全因死亡在两种策略间无显著差异(HR 0.81,95%CI 0.56-1.16)。

核心结论

  • 在选择的STEMI合并多支病变患者中,完全血运重建策略与心血管死亡减少相关。
  • 该减少与心肌梗死和重复血运重建需求的减少同时出现。

研究设计与样本

  • 系统综述与荟萃分析,纳入6项比较完全血运重建与仅罪犯血管血运重建的随机临床试验。
  • 共纳入6528例患者(完全血运重建组3139例,仅罪犯血管组3389例)。
  • 采用随机效应通用逆方差法荟萃分析,随访1至3年(中位2年)。

主要发现

  • 心血管死亡在完全血运重建组显著降低(HR 0.62,95%CI 0.39-0.97,I2=29%)。
  • 心肌梗死显著减少(HR 0.68,95%CI 0.55-0.84,I2=0%)。
  • 重复冠状动脉血运重建显著减少(HR 0.29,95%CI 0.22-0.38,I2=36%)。
  • 全因死亡无显著影响(HR 0.81,95%CI 0.56-1.16,I2=27%)。
  • 预防一例心血管死亡的需治疗人数为70(95%CI 36-150)。

关键数值与推荐

  • 预防一例心血管死亡的需治疗人数为70(95%CI 36-150)。
  • 预防一例心肌梗死的需治疗人数为45(95%CI 37-55)。
  • 预防一例重复血运重建的需治疗人数为8(95%CI 5-13)。

临床怎么用

  • 对于STEMI合并多支病变患者,可考虑完全血运重建策略以降低心血管死亡、心肌梗死和重复血运重建风险。
  • 全因死亡未受显著影响,临床决策需综合评估患者个体情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The aim of this work was to investigate the prognostic impact of revascularization of non-culprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease by performing a meta-analysis of available randomized clinical trials (RCTs). METHODS AND RESULTS: Data from six RCTs comparing complete vs. culprit-only revascularization in STEMI patients with multivessel disease were analysed with random effect generic inverse variance method meta-analysis. The endpoints were expressed as hazard ratio (HR) with 95% confidence interval (CI). The primary outcome was cardiovascular death. Main secondary outcomes of interest were all-cause death, myocardial infarction (MI), and repeated coronary revascularization. Overall, 6528 patients were included (3139 complete group, 3389 culprit-only group). After a follow-up ranging between 1 and 3 years (median 2 years), cardiovascular death was significantly reduced in the group receiving complete revascularization (HR 0.62, 95% CI 0.39-0.97, I2 = 29%). The number needed to treat to prevent one cardiovascular death was 70 (95% CI 36-150). The secondary endpoints MI and revascularization were also significantly reduced (HR 0.68, 95% CI 0.55-0.84, I2 = 0% and HR 0.29, 95% CI 0.22-0.38, I2 = 36%, respectively). Needed to treats were 45 (95% CI 37-55) for MI and 8 (95% CI 5-13) for revascularization. All-cause death (HR 0.81, 95% CI 0.56-1.16, I2 = 27%) was not affected by the revascularization strategy. CONCLUSION: In a selected study population of STEMI patients with multivessel disease, a complete revascularization strategy is associated with a reduction in cardiovascular death. This reduction is concomitant with that of MI and the need of repeated revascularization.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Pavasini R, Biscaglia S, Barbato E, et al. Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials. Eur Heart J. 2020. PMID: 31891653. doi:10.1093/eurheartj/ehz896

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。